A spectrophotometric method for the estimation of the carcinostatic agent, 5-aziridino-2,4-dinitrobenzamide (CB 1954), in biological fluids.
D000085:Acetates; D000284:Administration, Oral; D000818:Animals; D000970:Antineoplastic Agents / Q000032:analysis* / Q000097:blood / Q000652:urine; D001389:Azirines / Q000008:administration & dosage / Q000032:analysis* / Q000097:blood / Q000627:therapeutic use / Q000652:urine; D001646:Bile / Q000032:analysis; D004285:Dogs; D004952:Esters; D000431:Ethanol; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy / Q000652:urine; D006801:Humans; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D008297:Male; D008433:Mathematics; D008722:Methods; D009374:Neoplasms, Experimental / Q000188:drug therapy / Q000652:urine; D011817:Rabbits; D051381:Rats; D012995:Solubility; D013053:Spectrophotometry; D013552:Swine; D014466:Ultraviolet Rays; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy / Q000652:urine
D000085:Acetates; D000970:Antineoplastic Agents; D001389:Azirines; D004952:Esters; D000431:Ethanol